These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 17998786

  • 1. Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial.
    Massidda B, Atzori F, Scanu A, Contu A, Farris A, Catino AM, Palmeri S, Minerba L, Ionta MT.
    Oncology; 2007; 72(1-2):17-26. PubMed ID: 17998786
    [Abstract] [Full Text] [Related]

  • 2. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
    Ardavanis A, Scorilas A, Tryfonopoulos D, Orphanos G, Missitzis I, Karamouzis M, Chrysochoou M, Sotiropoulou A, Arnogiannaki N, Ioannidis G, Pissakas G, Rigatos G.
    Oncologist; 2006 Jun; 11(6):563-73. PubMed ID: 16794236
    [Abstract] [Full Text] [Related]

  • 3. 5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study.
    Barni S, Visini M, Piazza E, Ionta MT, Ardizzoia A, Arnoldi E, Fava S, Pinotti G, Torretta F, Corradini G, Villa S, Nosenzo AM, Massidda B, Cazzaniga ME.
    Anticancer Res; 2007 Jun; 27(4C):3019-24. PubMed ID: 17695490
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG, Carey LA, Calvo BF, Sartor C, Sawyer L, Moore DT, Rosenman J, Ollila DW, Graham M.
    Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer.
    De Giorgi U, Giannini M, Frassineti L, Kopf B, Palazzi S, Giovannini N, Zumaglini F, Rosti G, Emiliani E, Marangolo M.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1165-9. PubMed ID: 16682141
    [Abstract] [Full Text] [Related]

  • 10. Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer.
    Nisticò C, De Matteis A, Rossi E, Carnino F, Valenza R, Agostara B, Bria E, Farris A, Cremonesi M, D'Ottavio AM, Vaccaro A, Garufi C, Giunta S, Botti C, Perrone F, Terzoli E.
    Anticancer Res; 2005 Jul 15; 25(2B):1343-8. PubMed ID: 15865089
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome.
    Gentilini O, Intra M, Gandini S, Peruzzotti G, Winnikow E, Luini A, Veronesi P, Galimberti V, Goldhirsch A, Veronesi U.
    J Surg Oncol; 2006 Oct 01; 94(5):375-9. PubMed ID: 16967462
    [Abstract] [Full Text] [Related]

  • 13. First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer.
    Fiorentini G, Tsetis D, Bernardeschi P, Varveris C, Rossi S, Kalogeraki A, Athanasakis E, Dentico P, Kanellos P, Biancalani M, Almarashdah S, Zacharioudakis G, Saridaki Z, Chalkiadakis G, Xynos E, Zoras O.
    Anticancer Res; 2003 Oct 01; 23(5b):4339-45. PubMed ID: 14666649
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Can we predict local recurrence in breast conserving surgery after neoadjuvant chemotherapy?
    Cebrecos I, Córdoba O, Deu J, Xercavins J, Rubio IT.
    Eur J Surg Oncol; 2010 Jun 01; 36(6):528-34. PubMed ID: 20444571
    [Abstract] [Full Text] [Related]

  • 17. [A prospective multicenter clinical trial of breast conserving therapy for early breast cancer in China].
    Zhang BN, Shao ZM, Qiao XM, Li B, Jiang J, Yang MT, Wang S, Song ST, Zhang B, Yang HJ.
    Zhonghua Zhong Liu Za Zhi; 2005 Nov 01; 27(11):680-4. PubMed ID: 16438891
    [Abstract] [Full Text] [Related]

  • 18. [The application of conservative surgery for local advanced and bigger primary breast carcinoma].
    Li JF, Ouyang T, Wang TF, Xie YT, Lin BY.
    Zhonghua Wai Ke Za Zhi; 2005 Aug 01; 43(15):1008-10. PubMed ID: 16194361
    [Abstract] [Full Text] [Related]

  • 19. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902.
    van Nes JG, Putter H, Julien JP, Tubiana-Hulin M, van de Vijver M, Bogaerts J, de Vos M, van de Velde CJ, Cooperating Investigators of the EORTC.
    Breast Cancer Res Treat; 2009 May 01; 115(1):101-13. PubMed ID: 18484198
    [Abstract] [Full Text] [Related]

  • 20. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F.
    Eur J Cardiothorac Surg; 2008 May 01; 33(5):829-36. PubMed ID: 18367406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.